Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TDP2 | O95551 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3019716 | 0.89 | MAPT (0.39) | MAPTLMNAALDH1A1SMN1; SMN2APAF1 | |
| SCHEMBL10317013 | 0.81 | LMNA (0.37) | MAPTLMNAALDH1A1SMN1; SMN2GAA | |
| SCHEMBL3016094 | 0.74 | ALDH1A1 (0.41) | MAPTLMNAALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL862162 | 0.73 | CYP1A2 (0.50) | MAPTALDH1A1SMN1; SMN2CYP1A2GAA | |
| SCHEMBL3476583 | 0.72 | L3MBTL1 (0.52) | MAPTALDH1A1SMN1; SMN2CYP1A2GAA | |
| SCHEMBL3020821 | 0.71 | CYP1A2 (0.47) | MAPTALDH1A1SMN1; SMN2CYP1A2GAA | |
| SCHEMBL20524386 | 0.71 | ALDH1A1 (0.48) | MAPTLMNAALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL31751791 | 0.71 | CYP1A2 (0.47) | MAPTALDH1A1SMN1; SMN2CYP1A2NPC1 | |
| SCHEMBL18137413 | 0.71 | CYP1A2 (0.47) | MAPTALDH1A1SMN1; SMN2CYP1A2NPC1 | |
| SCHEMBL3008182 | 0.71 | ALDH1A1 (0.50) | MAPTALDH1A1SMN1; SMN2CYP1A2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2195310-B1 | LUMINESCENT LANTHANIDE (III) CHELATES, CHELATING AGENTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2016-06-01 | — | — | EP | disclosed |
| US-8221719-B2 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | WALLAC OY (FI) | 2012-07-17 | — | — | US | disclosed |
| US-20100204442-A1 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | WALLAC OY (FI) | 2010-08-12 | — | — | US | disclosed |
| EP-2195310-A1 | LUMINESCENT LANTHANIDE (III) CHELATES, CHELATING AGENTS AND CONJUGATES DERIVED THEREOF | Wallac OY (FI) | 2010-06-16 | — | — | EP | disclosed |
| WO-2009030819-A1 | LUMINESCENT LANTHANIDE (III) CHELATES, CHELATING AGENTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2009-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204442-A1 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | LNPEP, SLC39A3, LAP3 | MAPT 2629/4885LMNA 1328/4885ALDH1A1 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.